Med hensyn til kardiovaskulær sikkerhed var der enighed om, at en kontraindikation ikke var berettiget, og at en revideret tekst til afsnit 4. 4 var tilstrækkelig.
With regards to cardiovascular safety, it was agreed that a contraindication was not warranted and that a revised wording for Section 4.4 was sufficient.